Ligand validation:9F3K

BGC: beta-D-glucopyranose

BGC is a Ligand Of Interest in 9F3K designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
9F3K_BGC_A_501	92%	93%	0.061	0.952	0.1	0.36	-	-	0	0	100%	1
9F3K_BGC_B_501	78%	94%	0.088	0.93	0.12	0.32	-	-	0	0	100%	1
9F3I_BGC_A_501	73%	90%	0.099	0.926	0.23	0.38	-	-	0	0	100%	1
8W8V_BGC_A_501	100%	70%	0.023	0.996	0.4	0.76	-	-	0	0	100%	1
5DVI_BGC_B_501	100%	57%	0.027	0.991	0.74	0.9	-	-	0	0	100%	1
1HHU_BGC_C_8	100%	67%	0.037	0.997	0.6	0.68	-	-	0	0	100%	1
9G11_BGC_A_601	100%	46%	0.037	0.995	1.24	0.84	1	-	1	0	100%	1
4IIG_BGC_B_950	100%	50%	0.035	0.987	0.78	1.13	-	2	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.